Tumor-specific promoter-driven adenoviral therapy for insulinoma.

about

Oncolytic viruses-immunotherapeutics on the rise.

P2860

Q38919107-6F6FB242-D8DB-4045-B3FF-3DD0420B2370

P2860

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

Item

http://www.wikidata.org/entity/Q54213312

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@en

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@nl

type

Item

label

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@en

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@nl

prefLabel

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@en

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@nl

P1476

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

@en

P2093

Alan Wei-Shun Tseng

http://www.w3.org/2001/XMLSchema#string

Chiachen Chen

http://www.w3.org/2001/XMLSchema#string

Mary B Breslin

http://www.w3.org/2001/XMLSchema#string

Michael S Lan

http://www.w3.org/2001/XMLSchema#string

P2860

The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells

Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.

INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors

Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector.

Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene.

MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.

Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

P2888

s13402-016-0274-8

P304

279-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13402-016-0274-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26902080

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

about

P2860

P2860

Tumor-specific promoter-driven adenoviral therapy for insulinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921